Familial chylomicronemia syndrome: An expert clinical review from the National Lipid Association
Top Cited Papers
- 22 March 2025
- journal article
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 19 (3) , 382-403
Abstract
No abstract availableKeywords
This publication has 95 references indexed in Scilit:
- The Use of Orlistat in an Adult with Lipoprotein Lipase Deficiency: A Case ReportAACE Clinical Case Reports, 2021
- Effectiveness and safety of lomitapide in a patient with familial chylomicronemia syndromeEndocrine, 2020
- Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special IssueJournal of Clinical Apheresis, 2019
- Chylomicronemia: Differences between familial chylomicronemia syndrome and multifactorial chylomicronemiaAtherosclerosis, 2019
- Disappearance of recurrent pancreatitis after splenectomy in familial chylomicronemia syndromeAtherosclerosis, 2018
- Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an “FCS score”Atherosclerosis, 2018
- Clinical features and treatment of hypertriglyceridemia‐induced acute pancreatitis during pregnancy: A retrospective studyJournal of Clinical Apheresis, 2016
- Severe Hypertriglyceridemia With PancreatitisJAMA Internal Medicine, 2014
- Deletion of GPIHBP1 causing severe chylomicronemiaJournal of Inherited Metabolic Disease, 2011
- Concerns About Heparin Therapy for HypertriglyceridemiaArchives of internal medicine (1960), 2010